Clinical Trial

Keeping RAASi Treatment With Optimal Potassium Control

Study acronym: KEEP-ON
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 29, 2024 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Phase III, multicenter, randomized, open-label, parallel-group, non-inferiority, phase III clinical trial comparing CSZ (Lokelma) vs. iSRAA discontinuation/reduction and/or ARM (standard treatment).
Trial Details
NCT Number NCT06578533
Lead Sponsor Fundación para la Investigación del Hospital Clínico de Valencia
Conditions Chronic Kidney Diseases
Enrollment 78 participants
Start Date 2022-09-30
Primary Completion 2025-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-29